Faeth Therapeutics, Inc.

FTH Healthcare Biotechnology

In the quarter to June 2026, EPS grew 27.4% and free cash flow fell 174.2%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

18.80 1.80 −8.74%
Market cap
$532.3M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Total current assets
21.51 41.93 67.25 108.59 148.54 20.08 0.50 1.28
Total non-current assets
1.40 3.43 7.12 9.79 4.68 1.35 0.72 —
Total Assets
22.90 45.36 74.37 118.38 153.23 21.43 1.22 1.85
Total current liabilities
4.25 5.45 5.64 9.07 4.89 4.83 21.71 2.66
Total non-current liabilities
0.06 1.53 3.84 5.90 1.82 73.04 48.17 —
Total liabilities
4.31 6.98 9.48 14.97 6.71 77.87 69.88 7.79
Common Equity (Total)
18.59 38.39 64.90 103.41 146.51 (56.44) (68.66) (53.48)
Shareholders Equity (Total)
18.59 38.39 64.90 103.41 146.51 (56.44) (68.66) (5.93)
Total Debt
— 0.10 0.77 1.58 1.67 0.65 16.06 4.75

Show all line items

In millions of $ except per-share values · columns are period end dates